ProCE Banner Activity

Key Questions in the Management of Newly Diagnosed Multiple Myeloma

Clinical Thought

Read expert responses to key questions in the management of patients with newly diagnosed myeloma from a live event focused on incorporating CD38 monoclonal antibodies into the treatment paradigm.

Released: August 14, 2024

Expiration: August 13, 2025

Share

Faculty

Michele Cavo

Michele Cavo, MD

Head, “Seràgnoli” Institute of Hematology
Director, Postgraduate Residency in Hematology
Full Professor of Hematology
Department of Medical and Surgical Sciences
Bologna University School of Medicine
Bologna, Italy

Francesca Gay

Francesca Gay, MD, PhD

Associate Professor
Department of Molecular Biotechnology and Health Science
University of Torino
SC Ematologia 1
AOU Citta della Salute e della Scienza
Torino, Italy

Paul G. Richardson

Paul G. Richardson, MD

Director of Clinical Research
Clinical Program Leader
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
RJ Corman Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Provided by

Provided by Clincial Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Sanofi.

Sanofi

Disclosure

Primary Author

Michele Cavo, MD

Head, “Seràgnoli” Institute of Hematology
Director, Postgraduate Residency in Hematology
Full Professor of Hematology
Department of Medical and Surgical Sciences
Bologna University School of Medicine
Bologna, Italy

Michele Cavo, MD: consultant/advisor/speaker: AbbVie, Bristol Myers Squibb, Celgene, GlaxoSmithKline, Janssen, Kite, Menarini Stemline, Pfizer, Regeneron, Sanofi.

Francesca Gay, MD, PhD

Associate Professor
Department of Molecular Biotechnology and Health Science
University of Torino
SC Ematologia 1
AOU Citta della Salute e della Scienza
Torino, Italy

Francesca Gay, MD, PhD: consultant/advisor/speaker: AbbVie, Bristol Myers Squibb, Celgene, GSK, Janssen, Pfizer, Roche, Sanofi, Takeda.

Paul G. Richardson, MD

Director of Clinical Research
Clinical Program Leader
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
RJ Corman Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Paul G. Richardson, MD: consultant: Celgene/Bristol Myers Squibb, GlaxoSmithKline, Karyopharm, Oncopeptides, Regeneron, Sanofi; researcher: Oncopeptides.